Summary
The occurrence of breast cancer during pregnancy is a rare clinical situation. However, if it is diagnosed, a multidisciplinary approach involving an obstetrician, a medical oncologist and a surgeon is needed. In this situation, breast cancer should be treated according to the same principles applied in nonpregnant patients. Termination of pregnancy does not improve survival. Decisions regarding abortion should be based on the desires of the patient and on therapeutic necessities.
If required, surgery is always possible, but radiation therapy should be avoided because of the risk of fetal toxicity. Antineoplastic drug therapy, if indicated, is possible after the first trimester.
Similar content being viewed by others
References
Betson JR, Golden ML. Cancer and pregnancy. Am J Obstet Gynecol 1961; 81: 718–28
Moolgavkarsh, Day NE, Stevens RG. Two-stage model for carcinogenesis. Epidemiology of breast cancer in females. J Natl Cancer Inst 1980; 65: 559–69
Wallack MK, Wolf JA, Bedwinek J, et al. Gestational carcinoma of the female breast. Curr Prob Cancer 1983; 7: 1–58
Anderson JM. Mammary cancers and pregnancy. BMJ 1979; 1: 1124–7
Treves N, Holleb AI. A report of 549 cases of breast cancer in women 35 years of age or younger. Surg Gynecol Obstet 1958; 107: 271–83
Birks DM, Crawford GM, Elleson LG, et al. Carcinoma of the breast in women 30 years of age or less. Surg Gynecol Obstet 1973; 137: 21–7
Hoover H. Breast cancer during pregnancy and lactation. Surg Clin North Am 1990; 70: 1151–63
Barnavon Y, Wallack M. Management of the pregnant patient with carcinoma of the breast. Surg Gynecol Obstet 1990; 171: 347–52
Sickles EA, Filly A, Callen PW. Breast cancer detection with sonography and mammography: comparison using state-of-the-art equipment. AJR 1983; 140: 843
Max MH, Klamer TW. Pregnancy and breast cancer. South Med J 1983; 76: 1088–90
Finley JL, Silverman JF, Lannin DR. Fine needle aspiration cytology of breast masses in pregnant and lactating women. Diag Cytopathol 1989; 5: 255–60
Majmudar B, Rosales-Quintana S. Infarction of breast fibroadenomas during pregnancy. JAMA 1975; 231: 963–4
Byrd BF, Bayer DS, Robertson JC, et al. Treatment of breast tumors associated with pregnancy and lactation. Ann Surg 1962; 155: 940–7
White TT. Carcinoma of the breast and pregnancy. Ann Surg 1954; 139: 9–18
Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer 1991; 67: 869–72
Clark RM, Reid J. Carcinoma of the breast in pregnancy and lactation. Int J Radiation 1978; 4: 693–8
Giacalone PL, Bonnier P, Laffargue F, et al. Cancer du sein pendant la grossesse: etude multicentrique à propos de 178 cas. XVI Journées Nationales de la Société Française de Sénologie et de Pathologie Mammaire. 1994 Oct; Dijon: 275–92
Petrek JA. Breast cancer during pregnancy. Cancer 1994; 74: 518–27
Applewhite R, Smith LR, Divicenti F. Carcinoma of the breast with pregnancy and lactation. Am Surg 1973; 39: 101–4
Nagent P, O’Connell TX. Breast cancer and pregnancy. Arch Surg 1985; 120: 1221–4
Adami HO, Malker B, Holmberg L, et al. The relation between survival and age at diagnosis in breast cancer. N Engl J Med 1986; 315: 559–63
Host H, Lund E. Age as a prognostic factor in breast cancer. Cancer 1986; 57: 2217–21
Schoultz E, Johansson H, Wilking N. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 1995; 13: 430–4
Miller R, Mulvihill S. Small head size after atomic radiation. Teratology 1976; 14: 355–7
Barron WM. The pregnant surgical patient: medical evaluation and management. Ann Intern Med 1984; 101: 683–91
Stewart A, Webb D, Giles D, et al. Malignant disease in childhood and diagnostic irradiation in utero. Lancet 1956; 1:447–8
Mattison DR, Angtraco T. Magnetic resonance imaging in prenatal diagnosis. Clin Obstet Gynecol 1988; 31: 353–89
Inbar MJ, Ron IG. Breast-conserving surgery and adjuvant chemotherapy in pregnancy. Acta Obstet Gynecol Scand 1996; 75: 765–7
Timothy AR, Saunders JE. Radiation and pregnancy. In: Allen HH, Nisker JA, editors. Cancer in pregnancy: therapeutic guidelines. Mount Kisco, New York: Futura Publishing Co., 1986: 35–67
Saunders CM, Baum M. Breast cancer and pregnancy: a review J R Soc Med 1993; 86: 162–5
Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16(5): 337–46
Greenberg LH, Tanaka KR. Congenital anomalies probably induced by cyclophosphamide. JAMA 1964; 188: 423–6
Pirani BBK, Campbell DM, Macgillivary I. Plasma volume in normal first pregnancy. J Obstet Gynaecol Br Commonw 1973; 80: 884–7
Wan SH, Huffman DH, Azarnoff DL, et al. Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res 1974; 34: 3487–91
Redmond GP. Physiological changes during pregnancy and their implications for pharmacological treatment. Clin Invest Med 1985; 8: 317–22
Roboz J, Gleicher N, Wu K, et al. Does doxorubicin cross the placenta? Lancet 1979; II: 1382–3
Karp GI, von Oyen P, Roboz J, et al. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep 1983; 67: 773–7
Gaillard B, Leng JJ, Grellet J, et al. Passage transplacentaire de l’épirubicine. J Gynecol Obstet Biol Reprod 1995; 24: 63–8
Nicholson HO. Cytotoxic drugs in pregnancy. J Obstet Gynaecol Br Commonw 1968; 75: 307–12
Schapira DV, Chudley AE. Successful pregnancy following continuous treatment with combination chemotherapy before conception and throughout pregnancy. Cancer 1984; 54: 800–3
Doll DC, Ringenberg S, Yarbro DW. Management of cancer during pregnancy. Arch Intern Med 1988; 148: 2058–64
Willemse PHB, van der Sijde R, Sleijer DIH. Combination chemotherapy and radiation for stage IV breast cancer during pregnancy. Gynecol Oncol 1990; 36: 281–4
Gilliland J, Weinstein L. The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv 1983; 38: 6–13
Toledo TM, Harper RC, Moser RH. Fetal effects during cyclophosphamide and irradiation therapy. Ann Intern Med 1971; 74: 87–91
VJ Wiebe, Sipila P. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 1994; 16: 75–112
Zemlickis D, Lishner M, Degendorfer P, et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992; 152: 573–6
Sutcliffe SB. Treatment of neoplastic disease during pregnancy: maternal and fetal effects. Clin Invest Med 1985; 8: 333–8
Schaison G, Jacquillat C, Auclert G, et al. Les risques foetoembryonnaires des chimiothérapies. Bull Cancer 1979; 66: 165–70
Barber HRK. Fetal and neonatal effects of cytotoxic agents. Obstet Gynecol 1981; 58: 41S–7S
Reynoso E, Sheperd F, Messner H, et al. Acute leukemia in pregnancy: the Toronto leukemia study group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 1987; 5: 1098–106
Cuvier C, Espié M, Extra JM, et al. Vinorelbine in pregnancy. Eur J Cancer 1997; 33(1): 168–9
Barni S, Ardizzola A, Zanetta G, et al. Weekly doxorubicin chemotherapy for breast cancer in pregnancy: a case report. Tumori 1992; 78: 349–50
Dreicer R, Love R. High total dose — fluorouracil treatment during pregnancy. Wis Med J 1991; 90(10): 582–3
Meador JM, Armentrout SA, Slater LM. Third trimester chemotherapy and neonatal hematopoiesis. Cancer Chemother Pharmacol 1987; 19: 177–9
Blatt J, Bleyer WA. Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott, 1989: 1003–25
Aviles A, Niz J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol 1988; 16: 3–6
Aviles A, Diaz-Maqueo JC, Talavera A, et al. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 1991; 36: 243–8
Mulvihill JJ, Byrne J, Steinhorn SA, et al. Genetic disease in offspring of survivors of cancer in the young. Am J Hum Genet 1986; 39 Suppl.: A72
Garber JE. Long-term follow-up of children exposed in utero to antineoplastic agents. Semin Oncol 1989; 16(5): 437–44
King RM, Welch JS, Martin JL, et al. Carcinoma of the breast associated with pregnancy. Surg Gynecol Obstet 1985; 160: 228–32
Clark RM, Chua T. Breast cancer and pregnancy the ultimate challenge. Clin Oncol 1989; 1: 11–8
Hochman A, Schneber H. Pregnancy and cancer of the breast. Obstet Gynecol 1953; 2: 268–76
Bunker ML, Peters MV. Breast cancer associated with pregnancy or lactation. Am J Obstet Gynecol 1963; 85: 312–21
Cullins SL, Pridjian G, Sutherland CM. Goldenhars syndrome associated with tamoxifen given to the mother during gestation. JAMA 1994; 271(24): 1905–6
Dildy GA, Moise KJ, Carpenter RJ. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv 1989; 44: 535–40
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Espié, M., Cuvier, C. Treating Breast Cancer During Pregnancy. Drug-Safety 18, 135–142 (1998). https://doi.org/10.2165/00002018-199818020-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199818020-00005